These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8883032)

  • 1. Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes.
    Mattar AL; Fujihara CK; Ribeiro MO; de Nucci G; Zatz R
    Nephron; 1996; 74(1):136-43. PubMed ID: 8883032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nitric oxide in renal function in rats with short and prolonged periods of streptozotocin-induced diabetes.
    Suanarunsawat T; Klongpanichapak S; Chaiyabutr N
    Diabetes Obes Metab; 1999 Nov; 1(6):339-46. PubMed ID: 11225650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO.
    Tolins JP; Shultz PJ; Raij L; Brown DM; Mauer SM
    Am J Physiol; 1993 Dec; 265(6 Pt 2):F886-95. PubMed ID: 7506873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes.
    Komers R; Allen TJ; Cooper ME
    Diabetes; 1994 Oct; 43(10):1190-7. PubMed ID: 7926287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
    Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ
    Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats.
    Choi KC; Lee SC; Kim SW; Kim NH; Lee JU; Kang YJ
    Korean J Intern Med; 1999 Jan; 14(1):32-41. PubMed ID: 10063312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
    Schwartz D; Schwartz IF; Blantz RC
    J Lab Clin Med; 2001 Feb; 137(2):107-14. PubMed ID: 11174467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide.
    De Vriese AS; Stoenoiu MS; Elger M; Devuyst O; Vanholder R; Kriz W; Lameire NH
    Kidney Int; 2001 Jul; 60(1):202-10. PubMed ID: 11422752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
    Kramer HJ; Horacek V; Bäcker A; Vaneckova I; Heller J
    Kidney Blood Press Res; 2004; 27(1):10-7. PubMed ID: 14583658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of impaired vascular reactivity in a rat model of diabetic nephropathy: effect of nitric oxide synthesis inhibition on intrarenal diffusion and oxygenation measured by magnetic resonance imaging.
    Hueper K; Hartung D; Gutberlet M; Gueler F; Sann H; Husen B; Wacker F; Reiche D
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1428-35. PubMed ID: 24005471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat.
    Ito A; Uriu K; Inada Y; Qie YL; Takagi I; Ikeda M; Hashimoto O; Suzuka K; Eto S; Tanaka Y; Kaizu K
    J Lab Clin Med; 2001 Sep; 138(3):177-85. PubMed ID: 11528370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats.
    Danielson LA; Conrad KP
    J Clin Invest; 1995 Jul; 96(1):482-90. PubMed ID: 7542284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.
    Polichnowski AJ; Licea-Vargas H; Picken M; Long J; Bisla R; Williamson GA; Bidani AK; Griffin KA
    Am J Physiol Renal Physiol; 2015 Nov; 309(9):F791-9. PubMed ID: 26109088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential renal response to Nomega-nitro-L-arginine methyl ester and L-arginine in rats with hypertensive or diabetic nephropathy.
    Erley CM; Heyne N; Friedrich B; Schmidt T; Strobel U; Wehrmann M; Osswald H
    J Cardiovasc Pharmacol; 2002 Nov; 40(5):780-8. PubMed ID: 12409987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure.
    Lahera V; Salom MG; Miranda-Guardiola F; Moncada S; Romero JC
    Am J Physiol; 1991 Dec; 261(6 Pt 2):F1033-7. PubMed ID: 1750517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-NAME and L-Arg on arterial blood pressure in normotensive and hypertensive streptozotocin diabetic rats.
    Costa MA; Balaszczuk AM; Domínguez A; Catanzaro O; Arranz C
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):59-63. PubMed ID: 9695876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal dysfunction after chronic blockade of nitric oxide synthesis.
    Cachofeiro V; Fortepiani LA; Navarro-Cid J; Lahera V; García-Estañ J
    Antioxid Redox Signal; 2002 Dec; 4(6):885-91. PubMed ID: 12573137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of an acute NaCl load in chronic nitric oxide blockade-induced hypertensive rats.
    Rodríguez-Pérez JC; Brenner BM
    J Physiol Biochem; 1998 Sep; 54(3):127-33. PubMed ID: 10217208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats.
    Thompson A; Valeri CR; Lieberthal W
    Am J Physiol; 1995 Aug; 269(2 Pt 2):H743-8. PubMed ID: 7653640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of blood pressure salt-sensitivity supports a preglomerular site of action of nitric oxide in Type I diabetic rats.
    Brands MW; Bell TD; Fleming C; Labazi H; Sturgis LC
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):475-9. PubMed ID: 17439418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.